Swojas Foods (530217)

Score breakdown: P/E: 0/3 · ROCE: 2/2 · Growth: 0/2 · Dividend: 0/1

Key Financials

Strengths

• Historical ROE of 38.39% and ROCE of 73.33% demonstrate strong capital efficiency in earlier periods, though not currently.
• Latest quarter sales of ₹33 crore show the company still has a revenue base matching its entire ₹33 crore market cap.
• Positive book value of ₹1.24 per share provides a thin, but positive, equity cushion.
• Price of ₹10.50 is well below the 52-week high of ₹20.80, reducing some of the earlier froth.

Concerns

• Profit growth has collapsed by 82.09% and the latest quarterly net profit is exactly ₹0 crore.
• Valuation is rich at P/E 31.86 and P/B 8.47 despite zero current earnings and book value of only ₹1.24.
• Piotroski F-Score of 3/9 points to weak and deteriorating financial health.
• Sales are declining by 7.85%, there is no dividend, and promoter holding is unavailable.

AI Analysis

At ₹10.50, Swojas Foods is a ₹33 crore market-cap packaged foods company that fails my first tests. I look for consistent earning power, and this business is going backwards. Profit growth has collapsed by 82.09%, and the latest quarter produced net profit of exactly ₹0 crore. A P/E of 31.86 on collapsing earnings is not a sign of value; it is a sign that the 'E' has evaporated. Sales are also shrinking by 7.85%, so there is no revenue momentum to justify hope. Book value is only ₹1.24 per share, yet the stock trades at 8.47 times book. That means I am paying a large premium for a small tangible net worth, while earning nothing today. The historical ROE of 38.39% and ROCE of 73.33% look fantastic, but they were achieved on a tiny equity base and are clearly not sustainable if quarterly profit is zero. The Piotroski F-Score of 3 out of 9 confirms a weak, deteriorating balance sheet. There is no dividend yield, so I receive no payment while waiting. Promoter holding is not available, which bothers me in a small stock because promoter commitment matters. This is not a wonderful business at a wonderful price; it is a troubled small-cap with an absent margin of safety. The 52-week range of ₹6.66 to ₹20.80 shows how much investors have already lost, and I do not see evidence that the pain is over. I would need to see several quarters of rising sales, positive net profit, and a stronger Piotroski score before I would study this further. For now, I simply cannot value it as a going concern with confidence. Patience is a virtue, and here patience means staying away.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer